Clinical Trial

A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Study acronym: Mini-CHAMP
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study was a randomized, double-blind, placebo-controlled, multicenter, superiority design, phase III clinical trial to compare the efficacy and safety of two low-concentration atropine sulfate eye drops versus placebo in delaying myopia progression in children.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-06; most recent amendment 2025-07-25.
Trial Details
NCT Number NCT06209281
Lead Sponsor Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Conditions Myopia
Enrollment 526 participants
Start Date 2022-05-13
Primary Completion 2023-08-20 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-30